×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| BAFNA PHARMACEUTICALS LTD. | 352.2 | 33.89 | 346.24 | 1.43 | 233.0 | 23.1 |
| NATURAL CAPSULES LTD. | 455.62 | -55.8 | 452.03 | -5.4 | 217 | 27.9 |
| PHARMAIDS PHARMACEUTICALS LTD. | NA | NA | NA | NA | 204 |
Bafna Pharmaceuticals Limited, with Security Code 532989, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42.2 | 41.9 | 40.7 | 28.4 | 41.4 | 33.3 | 40.3 | 33.2 | 39.1 | 34.6 |
| Expenses | 34.6 | 35.7 | 36.7 | 30.5 | 38.5 | 32.1 | 36.5 | 30.1 | 35.9 | 29.6 |
| Operating Profit | 7.6 | 6.3 | 4.0 | -2.1 | 2.9 | 1.2 | 3.8 | 3.1 | 3.2 | 5.1 |
| OPM % | 18.04% | 15.01% | 9.84% | -7.3% | 6.97% | 3.64% | 9.41% | 9.22% | 8.18% | 14.64% |
| Other Income | 0.3 | 1.9 | 0.2 | 1.0 | 0.5 | 0.2 | 1.0 | 0.2 | -0.8 | 0.6 |
| Interest | 0.7 | 0.6 | 0.4 | 0.6 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 0.9 |
| Depreciation | 1.5 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.6 | 1.7 | 0.2 | 1.4 |
| Profit before tax | 5.7 | 6.4 | 2.5 | -2.9 | 1.5 | -0.4 | 2.6 | 1.0 | 3.2 | 3.4 |
| Tax % | -4.9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 5.4 | 6.4 | 2.5 | -2.9 | 1.5 | -0.7 | 2.6 | 0.9 | 1.3 | 3.4 |
| EPS in Rs | 2.34 | 2.68 | 1.05 | -1.24 | 0.62 | -0.31 | 1.11 | 0.4 | 0 | 1.43 |
| Metrics | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 |
|---|---|---|---|---|
| Sales | 6.8 | 11.6 | 10.9 | 13.1 |
| Expenses | 9.7 | 11.9 | 10.5 | 9.2 |
| Operating Profit | -2.9 | -0.4 | 0.4 | 4.0 |
| OPM % | -41.86% | -3.23% | 3.86% | 30.13% |
| Other Income | 0.3 | 0.6 | -21.7 | -1.5 |
| Interest | 0.1 | 0.0 | 0.1 | 0.0 |
| Depreciation | 1.0 | 0.7 | 1.0 | 0.5 |
| Profit before tax | -3.7 | -0.6 | -0.6 | 2.7 |
| Tax % | -42.6% | 7.3% | -0.2% | -72.3% |
| Net Profit | -2.1 | -0.6 | -22.3 | 0.3 |
| EPS in Rs | -0.9 | -0.5 | -94.3 | 0.2 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 28% |
| 3 Years: | 29% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 19% |
| 3 Years: | 8% |
| TTM: | -59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 30% |
| 3 Years: | -16% |
| 1 Year: | -21% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -15% |
| 3 Years: | -13% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 14% |
| 3 Years: | 24% |
| TTM: | 90% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 30% |
| 3 Years: | -16% |
| 1 Year: | -21% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|